Live Breaking News & Updates on பாரத் பயோடெக் செய்தி
Stay updated with breaking news from பாரத் பயோடெக் செய்தி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While official data shows 2.1 crore doses of Covaxin had been administered across the country till Thursday, based on statements from Bharat Biotech and Centre, at least 6 crore doses should have been produced and available for vaccination ....
(Image source from: thehindu.com) Bharat Biotech urges to avoid Covaxin in case of Fever and Health Issues:- Bharat Biotech, Hyderabad based pharmaceutical company is busy producing the vaccine for the people of the country after it received an immediate approval for Covaxin. Bharat Biotech along with Serum Institute of India administered the vaccine and the first phase of the vaccination drive is currently going on. There are several speculations that Covaxin was given approval when the trials are in the third phase. Bharat Biotech issued a clarification that the vaccination should not be given to those who have the history of allergies, fever, bleeding disorder or any serious health issues. ....
Govt expert panel to review Bharat Biotech s COVID-19 vaccine Covaxin today Experts will review the indigenously developed vaccine a day after the Subject Expert Committee (SEC) had recommended Serum-Oxford s Covishield COVID-19 vaccine to the Drugs Controller General of India (DCGI) for emergency use authorisation BusinessToday.In | January 2, 2021 | Updated 16:22 IST Covaxin has been developed by Indian biotechnology firm Bharat Biotech in collaboration with ICMR A panel of government experts will today review Covaxin s emergency use application. The COVID-19 vaccine has been developed by Indian biotechnology firm Bharat Biotech in collaboration with the country s top medical research organisation - Indian Council for Medical Research (ICMR). ....